research Telogen Effluvium After Anesthesia and Surgery
Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.
Search
for
Sort by
Research
660-690 / 1000+ results 
research Topical Odorant Application of the Specific Olfactory Receptor OR2AT4 Agonist, Sandalore, Improves Telogen Effluvium-Associated Parameters
Sandalore® improves hair growth and quality in people with hair loss.
research Localized Telogen Effluvium Following Hair Transplantation
Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.
research The Role of Anemia and Vitamin D Levels in Acute and Chronic Telogen Effluvium
Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.
research Telogen Effluvium Secondary to Starvation Diet
Starving yourself can cause hair loss, but stopping the diet can improve it.
research Telogen Effluvium in Daily Practice: Patient Characteristics, Laboratory Parameters, and Treatment Modalities of 3028 Patients
Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.
research Integral Roles of Specific Proteoglycans in Hair Growth and Hair Loss: Mechanisms Behind the Bioactivity of Proteoglycan Replacement Therapy with Nourkrin with Marilex in Pattern Hair Loss and Telogen Effluvium
Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.
research Intermittent Chronic Telogen Effluvium
Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.
research Prevalence and Factors Associated with Telogen Effluvium in Adult Females at Makkah Region, Saudi Arabia: A Retrospective Study
Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.
research Evaluation of Anxiety and Levels of Serum B12, Folate, TSH, Ferritin, and Zinc in Telogen Alopecia Patients with Trichodynia
The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.
research Telogen Effluvium Secondary to Weight Loss and Therapy With Chorionic Gonadotropin
A woman's significant hair loss was linked to rapid weight loss and hormone injections.
research A Technique for More Precise Distinction Between Catagen and Telogen Human Hair Follicles Ex Vivo
Researchers developed a new method using methylene blue staining to more accurately identify the growth stage of human hair follicles.
research Comparative Evaluation Between Two Nutritional Supplements in the Improvement of Telogen Effluvium
One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.
research Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium
The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.
research The Postpartum Telogen Effluvium Fallacy
The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.
research Age-Related Diffuse Chronic Telogen Effluvium-Type Alopecia in Female Squirrel Monkeys (Saimiri Boliviensis Boliviensis)
Older female squirrel monkeys often experience a type of hair loss similar to chronic telogen effluvium in humans.
research A Falling Out Following Minoxidil: Telogen Effluvium
A man lost a lot of scalp hair quickly after stopping minoxidil, but it grew back with mild male pattern baldness.
research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity
COVID-19 patients may experience hair loss, but it's not linked to their age or sex.
research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.
research Ischemia-Modified Albumin as a Possible Marker of Oxidative Stress in Patients with Telogen Effluvium
Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.
research Chronic Telogen Effluvium and Female Pattern Hair Loss Are Separate and Distinct Forms of Alopecia: A Histomorphometric and Immunohistochemical Analysis
CTE and FPHL are different hair loss types with unique causes.
research Telogen Effluvium Following Bivalent Human Papillomavirus Vaccine Administration: A Report of Two Cases
The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.
research Telogen Effluvium Associated with Albendazole Therapy
Albendazole may cause hair loss.
research Characteristics of Telogen Effluvium in COVID-19 in Western Iran (2020)
COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.
research Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection
A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.
research Race, Ethnicity, and Comorbidities Are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID-19 Pandemic
Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.
research Postpartum Telogen Effluvium
Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.
research Telogen Effluvium and Trichodynia
Hair loss can cause scalp discomfort.
research Low-Dose Oral Minoxidil for Treatment of Androgenetic Alopecia and Telogen Effluvium in a Pediatric Population: A Descriptive Study
Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.
research Safety and Efficacy of ALRV5XR in Women with Androgenetic Alopecia or Telogen Effluvium: A Randomised, Double-Blinded, Placebo-Controlled Clinical Trial
ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.